SEPTIN9 and colorectal carcinoma: There are 25 independent studies performed so far to investigate the performance of the SEPT9 gene methylation assay in CRC detection, in which most studies were case-control or cohort studies, while only one randomized multi-center screening study and two opportunistic screening studies were performed to investigate its performance in average-risk population and high-risk population, respectively7, 9–11.